Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

0.2329
+0.00130.56%
Post-market: 0.23800.0051+2.19%19:59 EDT
Volume:2.17M
Turnover:503.37K
Market Cap:11.02M
PE:-0.41
High:0.2350
Open:0.2315
Low:0.2313
Close:0.2316
52wk High:7.88
52wk Low:0.2222
Shares:47.31M
Float Shares:26.07M
Volume Ratio:0.33
T/O Rate:8.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5692
EPS(LYR):-0.6446
ROE:-21.25%
ROA:-15.25%
PB:0.10
PE(LYR):-0.36

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Trump Media, Gold miners, Cracker Barrel

Reuters
·
Aug 26

Press Release: Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution

Dow Jones
·
Aug 26

ESSA Pharma Finalizes $80M Capital Distribution Amid Business Wind-up and Acquisition by XenoTherapeutics

Reuters
·
Aug 26

ESSA Pharma Announces Ex-Dividend Date Amidst Business Wind-Up and XenoTherapeutics Acquisition

Reuters
·
Aug 15

ESSA Pharma Q3 EPS $(0.09) Beats $(0.16) Estimate

Benzinga
·
Aug 13

XOMA Royalty Corporation Reports Q2 2025 Net Income of $9.2M, Cash Receipts Rise to $11.7M

Reuters
·
Aug 13

BVF Partners L.P. Reports Disposal of Common Shares of ESSA Pharma Inc

Reuters
·
Aug 08

ESSA Pharma Inc - Announces US$80 Mln Cash Distribution to Shareholders

THOMSON REUTERS
·
Aug 07

ESSA Pharma Inc. Publishes Shareholder Letter for Fiscal Year 2025

Reuters
·
Aug 01

Press Release: ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders

Dow Jones
·
Jul 24

ESSA Pharma Inc. Schedules Shareholder Meeting to Vote on Proposed Business Combination with XenoTherapeutics

Reuters
·
Jul 24

BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction

Reuters
·
Jul 14

ESSA Pharma Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
May 09

BRIEF-ESSA Pharma Reports Financial Results For Fiscal Second Quarter Ended March 31, 2025

Reuters
·
May 08